Markus Stenemo
Impact in
-
- Heart Failure Treatment and Management
- Cardiovascular Function and Risk Factors
- Atrial Fibrillation Management and Outcomes
- Cardiac Fibrosis and Remodeling
-
- GDF15 and Related Biomarkers
Papers in
-
- Metabolomics and Mass Spectrometry Studies 2
- S100 Proteins and Annexins 2
- Ginseng Biological Effects and Applications 1
-
- Chronic Kidney Disease and Diabetes 2
- Co-authors
- Lars Lind (7 shared papers)Johan Ärnlöv (6 shared papers)Johan Sundström (6 shared papers)Erik Ingelsson (4 shared papers)Tove Fall (3 shared papers)Agneta Siegbahn (1 shared paper)Bertil Lindahl (1 shared paper)Emil Hagström (1 shared paper)
- Journals
- European Journal of Heart Failure (1 paper)Clinical Journal of the American Society of Nephrology (1 paper)Heart (1 paper)European Journal of Preventive Cardiology (1 paper)Frontiers in Pharmacology (1 paper)
- Partner nations
- SwedenUnited StatesAustralia
In The Last Decade
Markus Stenemo
9 papers receiving 362 citations
Peers
Comparison fields: 5 of 82
- Cardiology and Cardiovascular Medicine 109
- Rheumatology 61
- Nephrology 25
- Physiology 63
- Immunology 49
Countries citing papers authored by Markus Stenemo
This map shows the geographic impact of Markus Stenemo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Stenemo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Stenemo more than expected).
Fields of papers citing papers by Markus Stenemo
This network shows the impact of papers produced by Markus Stenemo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Stenemo. The network helps show where Markus Stenemo may publish in the future.
Co-authors
The 25 scholars most cited alongside Markus Stenemo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 76 | |
| 2 | 2015 | 75 | |
| 3 | 2016 | 56 | |
| 4 | 2015 | 55 | |
| 5 | 2017 | 45 | |
| 6 | 2019 | 29 | |
| 7 | 2016 | 14 | |
| 8 | 2022 | 9 | |
| 9 | 2016 | 6 |
About Markus Stenemo
Markus Stenemo is a scholar working on Molecular Biology, Nephrology, Cardiology and Cardiovascular Medicine, Epidemiology and Rheumatology, having authored 9 papers that have together received 365 indexed citations. Recurring topics across this work include Atherosclerosis and Cardiovascular Diseases (2 papers), Chronic Kidney Disease and Diabetes (2 papers), Protease and Inhibitor Mechanisms (2 papers), Advanced Proteomics Techniques and Applications (2 papers), GDF15 and Related Biomarkers (2 papers), Metabolomics and Mass Spectrometry Studies (2 papers), S100 Proteins and Annexins (2 papers) and Ginseng Biological Effects and Applications (1 paper). The work is most often cited by research in Cardiology and Cardiovascular Medicine (109 citations), Rheumatology (61 citations), Nephrology (25 citations), Physiology (63 citations) and Immunology (49 citations). Markus Stenemo has collaborated with scholars based in Sweden, United States and Australia. Frequent co-authors include Lars Lind, Johan Ärnlöv, Johan Sundström, Erik Ingelsson, Tove Fall, Agneta Siegbahn, Bertil Lindahl, Emil Hagström, Vilmantas Giedraitis and Christoph Nowak. Their work appears in journals such as European Journal of Heart Failure, Clinical Journal of the American Society of Nephrology, Heart, European Journal of Preventive Cardiology and Frontiers in Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.